Table 2.

Quantification of responsive cells due to ischemic treatment (cells/μL).

	Number of Positive Cells /μL		Fold Change
	Day 0	Day 3	(Day 3/0)	t-test
CD34 subpopulations
CD34+/CD31+/CD45-	32.91±25.80	56.04±80.74	1.75	0.49
CD34+/CD195+/CD45-	77.73±125.83	23.48±35.33	0.29	0.15
CD34+/CXCR4+/CD45-	16.21± 24.62	14.20±16.41	0.87	0.81
CD34+/CD14+	62.56±63.90	49.34±47.34	0.78	0.14
CD34+/CD14+/CD45-	34.69±44.21	147.7±281.9	4.25	0.31
CD117 subpopulations
CD117+/CD45-	22.94±26.57	47.17±35.34	2.05	0.20
CD117+/CD31+/CD45-	8.04±7.03	37.03±43.40	4.60	0.10
CD117+/CD34+/CD45+	0.34±0.53	0.56±0.58	1.64	0.23
CD117+/CD34+/CD45-	14.64±22.01	36.35±30.47	2.48	0.20
CD146 based-EPC
CD146+/CD54-/CD45-	48.22±34.19	319.85±220.75	6.63	0.009*
CD146+/UEA-1+/CD45-	8.89±16.64	108.6±171.5	12.21	0.14
Circulating EC
CD146+/CD54+/CD45-	10.51±14.55	10.04±13.28	0.95	0.93
CD54+/UEA-1+/CD45-	10.12±15.71	15.76±32.89	1.55	0.69
VEGFR3 based-EPC
VEGFR3+/CD181+/CD45-	16.33±18.31	42.95±53.14	2.63	0.20
VEGFR3+/CD45-	58.24±38.69	109.85±58.65	1.88	0.03*
VEGFR3+/CXCR4+	2.48±1.32	2.59±1.91	1.04	0.58
VEGFR3+/CXCR4+/CD45-	32.59±37.75	60.38±46.22	1.85	0.03*
CXCR4 subpopulations
CXCR4+/CD14+/CD45-	30.47±51.85	63.48±154.28	2.08	0.66
CXCR4+/CD181+/CD45-	11.08±12.48	56.88±118.37	5.13	0.35

Measures are mean ± SD, n=8,

^*p<0.05 t-test, mobilized (Day 3) vs. basal (Day 0) measures.